Last update: 12/03/21
Home
Covid-19 and Inflammation
Executive Board
Missions and actions
GREMI PhD Thesis Prize
Mediators of Inflammation
Laboratories about Inflammation
Meetings on Inflammation
Membership
Contact and Feedback
Websites on Inflammation
Scientific Journals on Inflammation
Archives
Upcoming GREMI Meeting
 
Sceau d'accréditation HONcode
Webmasters X. Norel (Email)
We comply with the HONcode standard for trustworthy health information.
© 2020-2023 GREMI, copyrights
 

Covid-19 and Inflammation


Scientific publications from GREMI members

Inflammation / Immunity

Respiration

Rheumathology

Tackling osteoarthritis during COVID-19 pandemic.
Castro da Rocha et al., Ann Rheum Dis. 2021 Feb;80(2):151-153.

Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis.
COVID-19 Global Rheumatology Alliance. Putman et al., Arthritis Rheumatol. 2021 Jan;73(1):36-47.

Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19.
Sattui et al., Expert Rev Clin Immunol. 2020 Jul;16(7):659-666.

Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist.
COVID-19 Global Rheumatology Alliance. Graef et al., Ann Rheum Dis. 2020 Jun;79(6):734-736.

A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19.
K
im et al., Ann Intern Med. 2020 Jun 16;172(12):819-821.

Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020. Richez et al., Joint Bone Spine. 2020 Oct;87(5):431-437.  

Kidney diseases

 

Other scientific publications

Dexamethasone in Hospitalized Patients with Covid-19.
RECOVERY Collaborative Group, N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.

Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans.
Arunachalam et al., Science. 2020 Sep 4;369(6508):1210-1220.

Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned.
Ryabkova et al., Clin Immunol. 2021 Feb;223:108652.


Animal models

Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.
Maisonnasse et al., Nature. 2020 Sep;585(7826):584-587.